Terms: = Head and neck cancer AND XPA, XPAC, 7507, ENSG00000136936, XP1, P23025 AND Treatment
7 results:
1. The DNA damage response network in the treatment of head and neck squamous cell carcinoma.
Psyrri A; Gkotzamanidou M; Papaxoinis G; Krikoni L; Economopoulou P; Kotsantis I; Anastasiou M; Souliotis VL
ESMO Open; 2021 Apr; 6(2):100075. PubMed ID: 33714009
[TBL] [Abstract] [Full Text] [Related]
2. 14-3-3σ confers cisplatin resistance in esophageal squamous cell carcinoma cells via regulating DNA repair molecules.
Lai KK; Chan KT; Choi MY; Wang HK; Fung EY; Lam HY; Tan W; Tung LN; Tong DK; Sun RW; Lee NP; Law S
Tumour Biol; 2016 Feb; 37(2):2127-36. PubMed ID: 26346170
[TBL] [Abstract] [Full Text] [Related]
3. High expression of xpa confers poor prognosis for nasopharyngeal carcinoma patients treated with platinum-based chemoradiotherapy.
Fu X; Hu J; Han HY; Hua YJ; Zhou L; Shuai WD; Du WY; Kuang CM; Chen S; Huang W; Liu RY
Oncotarget; 2015 Sep; 6(29):28478-90. PubMed ID: 26156020
[TBL] [Abstract] [Full Text] [Related]
4. The survival impact of xpa and XPC genetic polymorphisms on patients with esophageal squamous cell carcinoma.
Yang PW; Hsieh CY; Kuo FT; Huang PM; Hsu HH; Kuo SW; Chen JS; Lee JM
Ann Surg Oncol; 2013 Feb; 20(2):562-71. PubMed ID: 22941172
[TBL] [Abstract] [Full Text] [Related]
5. Validation of genetic sequence variants as prognostic factors in early-stage head and neck squamous cell cancer survival.
Azad AK; Bairati I; Samson E; Cheng D; Mirshams M; Qiu X; Savas S; Waldron J; Wang C; Goldstein D; Xu W; Meyer F; Liu G
Clin Cancer Res; 2012 Jan; 18(1):196-206. PubMed ID: 22076708
[TBL] [Abstract] [Full Text] [Related]
6. Role of eIF3a in regulating cisplatin sensitivity and in translational control of nucleotide excision repair of nasopharyngeal carcinoma.
Liu RY; Dong Z; Liu J; Yin JY; Zhou L; Wu X; Yang Y; Mo W; Huang W; Khoo SK; Chen J; Petillo D; Teh BT; Qian CN; Zhang JT
Oncogene; 2011 Dec; 30(48):4814-23. PubMed ID: 21625209
[TBL] [Abstract] [Full Text] [Related]
7. Expression of genes related to activity of oxaliplatin and 5-fluorouracil in endoscopic biopsies of primary esophageal cancer in patients receiving oxaliplatin, 5-flourouracil and radiation: characterization and exploratory analysis with survival.
Leichman L; Lawrence D; Leichman CG; Nava H; Nava E; Proulx G; Clark K; Khushalani NI; Berdzik J; Greco W; Smith P; Creaven PJ; Kepner JL; Javle MM; Pendyala L
J Chemother; 2006 Oct; 18(5):514-24. PubMed ID: 17127229
[TBL] [Abstract] [Full Text] [Related]
